参考文献/References:
[1]Rosenthal DI, Alexander A, Rosenberg AE, et al. Ablation of osteoid osteomas with a percutaneously placed electrode: a new procedure. Radiology, 1992, 183: 29-33.
[2]Lindner NJ, Ozaki T, Roedl R, et al. Percutaneous radiofrequency ablation in osteoid osteoma. J Bone Joint Surg Br, 2001, 83: 391-396.
[3]Barei DP, Moreau G, Scarborough MT, et al. Percutaneous radiofrequency ablation of osteoid osteoma. Clin Orthop, 2000, 373: 115-124.
[4]Berg JC, Pattynama PM, Obermann WR, et al. Percutaneous computed-tomography-guided thermocoagulation for osteoid osteomas. Lancet, 1995, 346: 350-351.
[5]Rosenthal DI, Springfield DS, Gebhart MC, et al. Osteoid osteoma: percutaneous radio-frequency ablation. Radiology, 1995, 197: 451-454.
[6]Torriani M, Rosenthal DI. Percutaneous radiofrequency treatment of osteoid osteoma. Pediatr Radiol, 2002, 32:615-618.
[7]Dupuy DE, Safran H, Mayo-Smith WW, et al. Radiofrequency ablation of painful osseous metastases [abstract]. Radiology, 1998, 209 (suppl):389.
[8]Callstrom MR, Charboneau JW, Goetz MP, et al. Percutaneous CT and ultrasound-guided radio-frequency ablation of painful metastases involving bone. proceedings of 3th international conference for percutaneous ablation therapies (PATs) of neoplastic diseases. Milan,2002,20-22.
[9]Mannion RJ, Woolf CJ. Pain mechanisms and management: A central perspective. Clin J Pain, 2000, 16: S144-S156.
[10]Honore P, Luger NM, Sabino MAC, et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nature Med, 2000, 6: 521-528.
[11]Goldberg SN, Saldinger PF, Gazelle GS, et al. Percutaneous tumor ablation: increased necrosis with combined Radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model. Radiology, 2001, 220: 420-427.
[12]Dupuy DE, Hong R, Oliver BS, et al. Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. AJR, 2000, 175: 1263-1266.
[13]Goldberg SN, Gazelle GS, Compton SS, et al. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol, 1995, 2: 776-784.
[14]Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet, 2000, 355: 479-485.
[15]Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous RF ablation of malignancies in the lung. AJR, 2000, 174: 57-60.
[16]Sewell PE, Jackson MD, Vance RB, et al. Assessing radiofrequency ablation of non-small cell lung cancer with positron emission tomography (PET) [abstract]. Radiology, 2000, 217(suppl): S551.
[17]King J, Glenn D, Clark W, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg, 2004, 91:217-223.
[18]Jeffrey SS, Birdwell RL, Ikeda DM, et al. Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg, 1999, 134: 1064-1968.
[19]Burak WE Jr, Agnese DM, Povoski SP, et al. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision. Cancer, 2003, 98: 1369-1376.
[20]Singletary ES.Feasibility of radiofrequnency ablation for primary breast cancer.Breast Cancer,2003,10:4-9.
[21]Noguchi M. Minimally invasive surgery for small breast cancer. J Surg Oncol, 2003, 84: 94-101.
[22]Izzo F, Thomas R, Delrio P, et al. Radiofrequency ablation in patients with primary breast carcinoma: a pilot study in 26 patients. Cancer, 2001, 92: 2036-2044.
[23]Hayashi AH, Silver SF, van der Westhuizen NG, et al. Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation. Am J Surg,2003, 185(5): 429-435.
[24]Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol, 2001, 166: 1611-1623.
[25]Rendon RA, Stanietzky N, Panzarella T, et al. The natural history of small renal masses. J Urol, 2000, 164: 1143-1147.
[26]Hall WH, McGahan JP, Link DP, et al. Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor. AJR, 2000, 174: 1592-1594.
[27]Goldberg SN, Gazelle GS, Compton CC, et al. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer, 2000, 88: 2452-2463.
[28]Zlotta AR, Wildschutz T, Raviv G, et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J Endourol, 1997, 11: 251-258.
[29]Gervais DA, McGovern FJ, Wood BJ, et al. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology, 2000, 217: 665-672.
[30]Lewin JS, Nour SG, Connell CF, et al. Follow up findings of a phase II trial of interactive MR-guided radiofrequency thermal ablation of primary kidney tumours[abstract]. Proceedings of 10th Scientific Meeting of the International Society for Magnetic Resonance in Medicine.Hawii,2002.18-24.
[31]Dupuy DE, Mayo-Smith WW, Cronan JJ. Image-guided biopsy and radiofrequency ablation of renal masses. Semin Interven Radiol, 2000,17:373-379.
[32]Raj GV, Reddan DJ, Hoey MB, et al. Management of small renal tumors with radiofrequency ablation. Urology, 2003, 61:23-29.
[33]Solbiati L, Ierace T, Dellanoce M, et al. Percutaneous US-guided radiofrequency ablation of metastatic lymph nodes from papillary cancer of the thyroid gland: initial experience in two cases. Radiology, 1998, 209 (Suppl):S385.
[34]Solbiati L, Goldberg SN, Ierace T, et al. Percutaneous US-guided ablation of parathyroid heperplasia: improved results using radio-frequency and ethanol in a single session. Radiology, 1997, 205 (suppl):S334.
[35]Ohhigashi S, Watanabe F. Radiofrequency ablation is useful for selected cases of pelvic recurrence of rectal carcinoma. Tech Coloproctol, 2003, 7:186-191.
[36]Goldberg SN, Mallery S, Gazelle GS, et al. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointest Endosc, 1999, 50: 392-401.